Post by IXICO
17,677 followers
Imaging is reshaping Parkinson’s disease clinical trials. Last chance to join IXICO’s webinar tomorrow “Understanding Imaging in Parkinson’s Disease Trials: From Eligibility to Efficacy” to explore how PET, SPECT and MRI can support participant selection, biomarker strategy and efficacy assessment in regulated CNS studies. Speakers: • Martijn Muller, Professor of Translational Neuroscience, The Manchester Metropolitan University • Kirsi Kinnunen, Principal Biomarker Scientist, IXICO • Moderated by Robin Wolz, CSO and CMO, IXICO Register today: https://lnkd.in/e25xjPwh #ParkinsonsDisease #ClinicalTrials #Neuroscience #Biomarkers #MedicalImaging
Video Content